NeuroOne Medical Technologies Corporation Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
NeuroOne Medical Technologies Corporation (NMTC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.60 per share for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-12-17
- NeuroOne Medical Technologies Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2018-03-31 was $2.30.
- NeuroOne Medical Technologies Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.60, a 52.38% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $1.26, a 18.71% decline from fiscal 2023.
- NeuroOne Medical Technologies Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $1.55, a 3.33% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $1.50, a 74.27% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.60 10-K · filed 2025-12-17 | |||
| 2024-09-30 | $1.26 10-K · filed 2025-12-17 | |||
| 2023-09-30 | $1.55 10-K · filed 2024-12-17 | |||
| 2022-09-30 | $1.50 10-K · filed 2022-12-22 | |||
| 2021-09-30 | $5.83 10-K · filed 2022-12-22 | |||
| 2020-09-30 | $6.18 10-K/A · filed 2022-05-31 | |||
| 2019-09-30 | $2.32 10-K · filed 2019-12-20 | |||
| 2018-09-30 | $5.34 10-K · filed 2019-12-20 | |||
| 2018-06-30 | $2.05 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | $2.30 10-Q · filed 2018-05-16 | |||
| 2017-12-31 | $0.03 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |